Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology and Public Health

• Re-emergence of chikungunya virus in China by 2025: What we know and what to do? (October 06, 2025)
• Epidemiology of Chikungunya Hospitalizations, Brazil, 2014-2024 (September 2025)
• Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns (June 10, 2025)
• The overlapping global distribution of dengue, chikungunya, Zika and yellow fever (April 10, 2025)
• Results of a Nationally Representative Seroprevalence Survey of Chikungunya Virus in Bangladesh. (June 29, 2024)
• Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study (April 24, 2024)
• Risk of death following chikungunya virus disease in the 100 Million Brazilian Cohort, 2015–18: a matched cohort study and self-controlled case series (February 08, 2024)
• Chikungunya: a decade of burden in the Americas. (February, 2024)
• Chikungunya: An Emerging Public Health Concern. (November 17, 2022)
• Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey. (January, 2021)
• Multisectoral Approach to Address Chikungunya Outbreaks Driven by Human Mobility: A Systematic Review and Meta-Analysis. (October 29, 2020)
• Differences in Transmission and Disease Severity Between 2 Successive Waves of Chikungunya (April 25, 2018)
• Chikungunya virus and the global spread of a mosquito-borne disease. (March 26, 2015) 

Clinical Features, Diagnosis, and Management

• Chikungunya fever: Epidemiology, clinical manifestations, and diagnosis (October 17, 2025)
• Differentiating dengue, Zika, and chikungunya in paediatric populations (September 2025)
• Chikungunya fever: Treatment and prevention (September 02, 2025)
• Perinatal outcomes of symptomatic chikungunya, dengue and Zika infection during pregnancy in Brazil: a registry-based cohort study (August 05, 2025)
• Clinical profile and management of a Spanish single-center retrospective cohort of patients with post-chikungunya associated complications. (May 15, 2024)
• Chikungunya fever (April 06, 2023)
• Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management. (October 16, 2019)
• Rheumatic manifestations of chikungunya: emerging concepts and interventions (September 03, 2019)
• Chikungunya, a Risk Factor for Guillain-Barré Syndrome (July 09, 2019)
• Severe Manifestations of Chikungunya Fever in Children, India, 2016 (September 2018)
• Misdiagnosis of Chikungunya Virus Infection: Comparison of Old and Younger Adults (August 06, 2018)
• Long-term sequelae of chikungunya virus disease: A systematic review (February 02, 2017)
• Host inflammatory response to mosquito bites enhances the severity of arbovirus infection (June 21, 2016)
• Chikungunya in children. (July 01, 2015)  

Microbiology and Pathogenesis

• Chikungunya virus and other emerging arthritogenic alphaviruses (May 07, 2025)
• Prevalence of dengue, Zika, and chikungunya virus infections among mosquitoes in Asia: A systematic review and meta-analysis (August 29, 2024)
• Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses (November 05, 2020)
• Clinical Characteristics, Histopathology, and Tissue Immunolocalization of Chikungunya Virus Antigen in Fatal Cases. (July 2, 2020)
• Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. (January 31, 2017)

Vaccination

• Surveillance for adverse events following use of live attenuated chikungunya vaccine, United States, 2024, and the associated public health response in 2024 and 2025 (August 14, 2025)
• Modeling the impact of vaccine campaigns on the epidemic transmission dynamics of chikungunya virus outbreaks (May 01, 2025)
• Chikungunya vaccine development, challenges, and pathway toward public health impact (October 09, 2024)
• Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents (September 05, 2024)
• A randomized, double-blinded phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults. (December 13, 2023)
• An Overview of Indian Biomedical Research on the Chikungunya Virus with Particular Reference to Its Vaccine, an Unmet Medical Need. (June 15, 2023)
• Chikungunya Virus Vaccine Candidate Incorporating Synergistic Mutations Is Attenuated and Protects Against Virulent Virus Challenge. (February 23, 2022)
• Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial. (April 14, 2020)
• Vaccine and Therapeutic Options To Control Chikungunya Virus. (December 13, 2017)